View in EDS HTML Full Text PDF Full Text

Safety and dosimetry of [177Lu]Lu-DOTA-TATE in adolescent patients with somatostatin receptor-positive gastroenteropancreatic neuroendocrine tumours, or pheochromocytomas and paragangliomas: Primary analysis of the Phase II NETTER-P study.

Saved in:
Bibliographic Details
Title: Safety and dosimetry of [177Lu]Lu-DOTA-TATE in adolescent patients with somatostatin receptor-positive gastroenteropancreatic neuroendocrine tumours, or pheochromocytomas and paragangliomas: Primary analysis of the Phase II NETTER-P study.
Authors: Gaze, Mark N.1 (AUTHOR), Handkiewicz-Junak, Daria2 (AUTHOR), Hladun, Raquel3 (AUTHOR), Laetsch, Theodore W.4 (AUTHOR), Sorge, Caryn5 (AUTHOR), Sparks, Richard6 (AUTHOR), Wan, Simon7 (AUTHOR), Ceraulo, Antony8 (AUTHOR), Kluczewska-Galka, Aneta2 (AUTHOR), Gámez-Cenzano, Cristina9 (AUTHOR), States, Lisa J.10 (AUTHOR), El Khouli, Riham5 (AUTHOR), Aimone, Paola11 (AUTHOR), Perraud, Kevin12 (AUTHOR), Kollar, Gabor13 (AUTHOR), Khanshan, Fariba14 (AUTHOR), Blumenstein, Lars15 (AUTHOR), Brouri, Fazia12 (AUTHOR), Giraudet, Anne-Laure16 (AUTHOR) annelaure.giraudet@lyon.unicancer.fr
Source: European Journal of Nuclear Medicine & Molecular Imaging. Sep2025, Vol. 52 Issue 11, p4001-4015. 15p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:16197070
DOI:10.1007/s00259-025-07246-7